Leading life sciences investors and companies throughout the U.S., Europe, Japan, and China choose us to help them enter, expand within, or grow outside of the Chinese life sciences market because of our experience in complex, cutting-edge cross-border commercial transactions and financings, our legendary scientific expertise in matters from IP strategic counseling to IP due diligence, and our long and storied track record working within the Chinese life science market. Our broad and deep bench of expert China life sciences attorneys, the array of services we provide to our clients, and the work we do for them earns us perennial recognition as one of the world’s premier China Life Sciences practices. We are proud to be the only firm ranked by third-party organizations in Asia and China for all of China Life Sciences, Global Life Sciences, Global Intellectual Property and Global Technology, M&A, Private Equity, and Venture Capital.
Why Choose Us
- Extensive Commercial Expertise in China
- Global and Regional Industry Knowledge
- 40 PhDs in Relevant Sciences
- Mandarin-Speaking Patent Partners
- 70 Attorneys in Hong Kong and the PRC
- Deep Understanding of Chinese Culture
Life Sciences Industry Expertise
- Pharmaceuticals
- Bioinformatics
- Biosimilars
- Biotechnology
- Nutraceuticals
- Formulations and Delivery Technologies
- Medical Devices
- Medicinal Chemicals
- Genetics and Epigenetics
- Diagnostics
- Vaccines
- Systems Diagnostics/Monitoring
- Materials Sciences
- Antibodies
- Regenerative Medicine
Core Service Capabilities
- Private Equity & Venture Capital
- Capital Markets
- IP Strategy & Licensing Strategic
- Alliances & Joint Ventures
- Mergers & Acquisitions
- Government Liaison